Mira Pharmaceuticals Files 8-K
Ticker: MIRA · Form: 8-K · Filed: Dec 19, 2024 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Mira Pharma filed an 8-K, nothing major to see here yet.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on December 19, 2024, reporting other events. The company, formerly known as Mira1a Therapeutics, Inc. until January 12, 2022, is incorporated in Florida and headquartered in Miami. The filing does not disclose specific financial transactions or material events beyond its routine reporting status.
Why It Matters
This 8-K filing indicates Mira Pharmaceuticals is making a regulatory submission, but it does not contain details of significant new events or financial changes.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not disclose any new material risks or adverse information.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former Company Name
- December 19, 2024 (date) — Date of Report
- Florida (location) — State of Incorporation
- Miami (location) — Principal Executive Offices City
FAQ
What is the primary purpose of this 8-K filing for Mira Pharmaceuticals, Inc.?
The 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting 'Other Events'.
When was Mira Pharmaceuticals, Inc. formerly known as Mira1a Therapeutics, Inc.?
The company was formerly known as Mira1a Therapeutics, Inc. until January 12, 2022.
Where is Mira Pharmaceuticals, Inc. headquartered?
The principal executive offices of Mira Pharmaceuticals, Inc. are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
What is the SIC code for Mira Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Mira Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date of this 8-K report?
The 8-K report was filed on December 19, 2024.
Filing Stats: 724 words · 3 min read · ~2 pages · Grade level 13.8 · Accepted 2024-12-19 08:30:13
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 36KB
- 0001493152-24-050695.txt ( ) — 210KB
- mira-20241219.xsd (EX-101.SCH) — 3KB
- mira-20241219_lab.xml (EX-101.LAB) — 33KB
- mira-20241219_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACUTICALS, INC. Dated: December 19, 2024 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer